BMS1P10: A Protein Implicated in Cancer, Neurodegenerative Diseases and Autoimmune Disorders

Target Name: BMS1P10

NCBI ID: G728611

BMS1P10

Other Name(s): BMS1 pseudogene 10

BMS1P10: A Protein Implicated in Cancer, Neurodegenerative Diseases and Autoimmune Disorders

BMS1P10 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the BMS1 gene family, which encodes a protein known as BMS1. While the exact function of BMS1 is not yet well understood, it is known to play a role in the regulation of cell survival and proliferation.

Recent studies have suggested that BMS1 may be a drug target or biomarker, and that it may be involved in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This has led to a great deal of interest in the research of BMS1 and its potential applications in medicine.

Diseases associated with BMS1

BMS1 has been implicated in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most well-studied associations with BMS1 is its role in the development of cancer. Several studies have shown that BMS1 is expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, experiments have suggested that inhibiting BMS1 may be an effective way to treat cancer. For example, one study found that inhibiting BMS1 in cancer cells led to a significant reduction in cell proliferation and the formation of new blood vessels.

Another area of research has focused on the role of BMS1 in neurodegenerative diseases. BMS1 has been shown to be expressed in the brains of individuals with Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Additionally, experiments have suggested that BMS1 may be involved in the development and progression of these diseases. For example, one study found that individuals with Alzheimer's disease had lower levels of BMS1 in their brain than those without the disease.

Finally, BMS1 has also been implicated in the development and progression of autoimmune disorders. Several studies have shown that BMS1 is expressed in the immune cells of individuals with rheumatoid arthritis, lupus, and other autoimmune disorders. Additionally, experiments have suggested that BMS1 may be involved in the development and progression of these disorders. For example, one study found that individuals with rheumatoid arthritis had lower levels of BMS1 in their immune cells than those without the disease.

Potential applications

The potential applications of BMS1 are vast and varied. In addition to its potential as a drug target or biomarker, BMS1 has also been shown to have a number of potential therapeutic applications, including the treatment of cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising applications of BMS1 is its potential as a drug target. BMS1 has been shown to play a role in the regulation of cell survival and proliferation, and it is thought to be involved in a variety of cellular processes. As such, BMS1 may be an attractive target for drugs that are designed to inhibit its activity. For example, one study found that inhibiting BMS1 in cancer cells led to a significant reduction in cell proliferation and the formation of new blood vessels.

Another potential application of BMS1 is its potential as a biomarker. BMS1 has been shown to be expressed in a variety of tissues and cells, including the brain, heart, and kidneys. As such, it may be a useful biomarker for the diagnosis and evaluation of a variety of diseases. For example, one study found that individuals with Alzheimer's disease had lower levels of BMS1 in their brain than those without the disease.

Conclusion

BMS1P10 is a protein that is expressed in various tissues of the body, and it is known to play a role in the regulation of cell survival and proliferation. While the exact function of BMS1 is not yet well understood, it is

Protein Name: BMS1 Pseudogene 10

The "BMS1P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BMS1P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets